Merck & Co (MRK) Stock Forecast & Price Target
Score
Merck & Co., Inc. price target
| MRK | |
|---|---|
| Low | $105.00 |
| Average | $160.47 |
| High | $180.00 |
| Upside vs current price | +9.0% |
The average target of $160.47 is +9.0% versus the current MRK price of $147.19.
Merck & Co., Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 5 |
| Buy | 14 |
| Hold | 9 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Buy |
28 analysts cover MRK.
Merck & Co., Inc. EPS and revenue estimates
MRK shows the next fiscal years with at least three analysts: 2026 EPS $2.77, 2027 EPS $8.95. A thinner year is left off this table.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $2.77 | $67.20B |
| 2027 | $8.95 | $69.46B |
Is Merck & Co., Inc. a buy or sell?
Of the 28 analysts covering Merck & Co., Inc., 19 rate it a buy (5 strong buy and 14 buy), 9 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The MRK consensus label is Buy, beside 19 buy-side ratings and 0 sell-side ratings.
The average target of $160.47 implies +9.0% versus the current price of $147.19.
Those 28 ratings on MRK are a headcount, and the label on file is Buy.
Reading the Merck & Co., Inc. forecast
The MRK target range is wide: $105.00 at the low end, $160.47 in the middle, and $180.00 at the top.
Set next to the $147.19 MRK quote, that average is +9.0%.
Ratings on the Merck & Co., Inc. cluster: 19 of 28 analysts are on the buy side, 9 are at hold, and 0 are on the sell side, and the published consensus is Buy.
Over the last few months MRK drew 2 upgrades and 1 downgrades.
The MRK average target is little changed, $160.13 over the last month and $159.81 over the last quarter.
28 analysts publish on MRK, so one note does not swing the average by itself.
Merck & Co., Inc. forecast questions
What is the MRK price target?
The published range for MRK is $105.00 to $180.00, with an average of $160.47. That average is +9.0% versus the current price of $147.19.
Is Merck & Co., Inc. a buy or sell?
Of the 28 analysts covering Merck & Co., Inc., 19 rate it a buy, 9 rate it a hold, and 0 rate it a sell. The consensus is Buy, and the MRK headcount is 19 buy, 9 hold, and 0 sell.
What is the EPS estimate for Merck & Co., Inc.?
Analyst EPS estimates for Merck & Co., Inc.: 2026 $2.77, 2027 $8.95.
What is the revenue estimate for Merck & Co., Inc.?
Analyst revenue estimates for Merck & Co., Inc.: 2026 $67.20B, 2027 $69.46B.
How many analysts cover MRK?
28 analysts cover MRK. Their consensus on MRK is Buy, across those 28.